Log In
Print this Print this

Lunesta, Lunivia, eszopiclone

Also known as: formerly Estorra

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionNon-benzodiazepine cyclopyrrolone GABA receptor modulator
Molecular Target GABA receptor
Mechanism of ActionGABA receptor modulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationInsomnia
Indication DetailsTreat chronic insomnia; Treat insomnia; Treat insomnia in patients with co-existing generalized anxiety disorder (GAD); Treat insomnia in patients with co-existing rheumatoid arthritis (RA); Treat insomnia in perimenopausal and menopausal women; Treat insomnia with co-existing major depressive disorder (MDD); Treat pediatric insomnia; Treat primary insomnia; Treat primary insomnia in elderly patients; Treat transient and chronic insomnia
Regulatory Designation
Partner Eisai Co. Ltd.; GlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today